Status:
ACTIVE_NOT_RECRUITING
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Lead Sponsor:
Federico Aucejo
Collaborating Sponsors:
Ohio State University
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
Eligibility Criteria
Inclusion
- Adult patients (age\>18 years) undergoing Liver transplant for hepatocellular carcinoma
Exclusion
- Patients under 18 years old
- Patients who do not have hepatocellular carcinoma
- patients who have hepatocellular carcinoma but do not undergo liver transplantation
Key Trial Info
Start Date :
May 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06018857
Start Date
May 11 2017
End Date
December 1 2026
Last Update
January 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
2
Ohio State University
Columbus, Ohio, United States, 43210